A gastrointestinal targeted therapy could reduce overall viral burden, inhibit disease progression, accelerate viral clearance, and block significant transmission routes.
Pulmotect, Inc., a clinical-stage biotechnology company and non-traditional Medical CBRN Defense Consortium (MCDC) member, is joining the fight against COVID-19.
Centivax and U.S. Naval Medical Research Center announce strategic partnership to initiate clinical development of a broad-spectrum injectable for COVID-19, with $4.2M from the Henry Jackson Foundation
"With discovery research supported by Medical Technology Enterprise Consortium, and now clinical development supported by our remarkable collaboration with the Naval Medical Research Center, this biotech-government partnership is proud to advance this molecule into clinical development and closer to the patients and doctors that need a better medicine to end the pandemic."
The DoD recently awarded Sibel Health $2.4 million through an MTEC award to support the developed and deployment of its wearable, COVID-19 monitoring sensor.
The enormity of the coronavirus threat called for a rapid response, and the MCDC OTA was a key factor in supporting an accelerated solution to help expand COVID-19 testing.
Inhalon Biopharma receives $7 million from USAMRDC to study inhaled “muco-trapping” antibody for the treatment of COVID-19
"We believe that Inhalon's inhaled therapy offers many attractive benefits for patients and the healthcare system that are not available with intravenous or other systemically-dosed treatments," said William Howell, president, Medical Technology Enterprise Consortium.
Vivacelle Bio, Inc., a non-traditional small business and Medical Technology Enterprise Consortium (MTEC) member, was awarded $5.3 million to research treatment of septic shock.
The Medical CBRN Defense Consortium (MCDC) used the power of collaboration to drive innovation in response to the COVID-19 outbreak.
With funding from the Medical Technology Enterprise Consortium (MTEC), Centivax is developing an optimized antibody therapeutic to treat, as well as protect against, COVID-19.
Just weeks into the pandemic, the Medical Technology Enterprise Consortium (MTEC) reached out to its members and the public to seek ways to detect pre-symptomatic exposure to the virus through wearable diagnostic technology.